Already a member?
Sign in
| Version | User | Scope of changes |
|---|---|---|
| Feb 22 2006, 2:26 PM EST (current) | mark | |
| Feb 22 2006, 2:17 PM EST | mark | 67 words added |
Changes
Key: Additions Deletions
Source: Forbes.com
Date: 02/15/06
Headline: Aspirin Derivative May Treat Recurrence of Ovarian Cancer
Women who are successfully treated for ovarian cancer often have a relapse of the disease, which becomes resistant to the cisplatin chemotherapy that worked before. Now, researchers have discovered that the new drug NCX-4016, an aspirin derivative, re-sensitizes ovarian cancer cells to chemotherapy with cisplatin and also kills ovarian cancer cells.
Date: 02/15/06
Headline: Aspirin Derivative May Treat Recurrence of Ovarian Cancer
Women who are successfully treated for ovarian cancer often have a relapse of the disease, which becomes resistant to the cisplatin chemotherapy that worked before. Now, researchers have discovered that the new drug NCX-4016, an aspirin derivative, re-sensitizes ovarian cancer cells to chemotherapy with cisplatin and also kills ovarian cancer cells.
